Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
← catalyst calendarSponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
760estimated
Sites
16
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-06-28 | actual | When the study began enrolling |
| Primary completion | 2026-06-30 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2035 | estimated | The whole study's end, after follow-up |
| First posted | 2023-03-28 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-10 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Knee Pain Chronic
- Osteoarthritis, Knee
- Rheumatoid Arthritis
- Traumatic Arthritis
- Polyarthritis
- Varus Deformity
- Valgus Deformity
- Flexion Deformity of Knee
- Avascular Necrosis
Intervention
- Device: Total Knee Arthroplasty
Primary outcome
what the primary-completion date above is the date OFOxford Knee Score (OKS)
measured 5 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed